These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2095345)

  • 1. Comparison of the diuretic effect and absorption of a single dose of furosemide and free and the fixed combinations of furosemide and triamterene in healthy male adults.
    van Meyel JJ; Tan Y; Smits P; Russel FG; van Ginneken CA; Gribnau FW
    Eur J Clin Pharmacol; 1990; 39(6):595-7. PubMed ID: 2095345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of magnesium sparing effect of a single dose of triamterene in combination with frusemide in healthy male adults.
    van Meyel JJ; Smits P; Gribnau FW
    Br J Clin Pharmacol; 1990 Nov; 30(5):774-7. PubMed ID: 2271378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the kaluretic properties of furosemide by triamterene (Dyrenium) in healthy volunteers.
    Levinson B; Shenouda M; Stypinski D
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):92-100. PubMed ID: 15726878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene.
    Heimsoth V; Loew D; Schuster O
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):161-4. PubMed ID: 3240762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diuretic effects of single dose frusemide/triamterene and hydrochlorothiazide/amiloride in healthy adults.
    Kohvakka A; Hussi E
    J Int Med Res; 1986; 14(4):188-92. PubMed ID: 3758469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of renin, aldosterone and antidiuretic hormone to furosemide and furosemide-triamterene combination.
    Lammintausta R; Anttila M; Viinamäki O
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):395-8. PubMed ID: 7005123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic study of the combination of furosemide retard and triamterene.
    Loew D; Barkow D; Schuster O; Knoell HE
    Eur J Clin Pharmacol; 1984; 26(2):191-5. PubMed ID: 6723757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental and clinical pharmacological study of the influence of triamterene on the diuretic and saluretic properties of furosemide xantinol].
    Celdrán E; Bekett PR; Roberts DJ
    Arzneimittelforschung; 1976; 26(11):2073-6. PubMed ID: 14648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and elimination kinetics of the combination furosemide-retard/triamterene.
    Schuster O; Loew D; Knoell HE
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):127-32. PubMed ID: 4043142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, natriuretic, antikaliuretic and antimagnesiuretic properties of an acidic triamterene derivative.
    Netzer T; Ullrich F; Majewski M; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):807-11. PubMed ID: 1418034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacodynamic and pharmacokinetic characteristics of furosemide and furesis].
    Noskov VB; Goncharov IB; Kovachevich IV; Kodratenko SN; Starodubtsev AK; Sokolova EV
    Eksp Klin Farmakol; 1999; 62(3):32-6. PubMed ID: 10439945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of frusemide and triamterene on the hypokalaemic and electrocardiographic responses to inhaled terbutaline.
    Newnham DM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1991 Nov; 32(5):630-2. PubMed ID: 1954079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localization of the action of furosemide and triamterene in the nephron by means of correlating their pharmacokinetics and pharmacodynamics].
    Lebedev AA; Munina II
    Farmakol Toksikol; 1989; 52(1):44-7. PubMed ID: 2707420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(11):1688-91. PubMed ID: 4091871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of furosemide with two furosemide-triamterene combinations in the treatment of cardiac insufficiency.
    Saarimaa H; Ojasalo T
    J Int Med Res; 1985; 13(4):236-40. PubMed ID: 4043516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
    Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
    Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of a diuretic combination versus single components].
    Pupita F; Ansuini R; Frausini G
    Clin Ter; 1984 Nov; 111(4):307-13. PubMed ID: 6396024
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats.
    Devane J; Ryan MP
    Br J Pharmacol; 1981 Feb; 72(2):285-9. PubMed ID: 7214099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a significant pharmacokinetic interaction between hydrochlorothiazide and triamterene when coadministered.
    Upton RA; Williams RL; Lin ET; Gee WL; Blume CD; Benet LZ
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):575-86. PubMed ID: 6533293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.